CODEXIS, INC. (CDXS) Reports the reporting period Financial Results
CODEXIS, INC. (CDXS) announced its financial results for the period ending the reporting period.
Key Financial Highlights:
Revenue: 360
Net Income: Not disclosed
EPS: Not disclosed
Cash and equivalents: 27172
Codexis hosted three key presentations at the 2026 TIDES US annual meeting that took place in May. These presentations demonstrated enzyme
driven stereoisomer control of siRNA using ECO Synthesis technology, the superior performance of Codexis ligase in siRNA ligation reactions, and the metrics of improved sustainability of the ECO Synthesis manufacturing platform compared to Solid
Phase Oligonucleotide Synthesis, the current industry manufacturing standard. These presentations have generated strong interest in both startup and established participants in the siRNA field.
📋 CODEXIS, INC. (CDXS) - Financial Results
Filing Date: 2026-08-11
Accepted: 2026-08-11 16:11:09
Event Type: Financial Results
Event Details:
📊 Key Financial Metrics (Year-over-Year Comparison):
💼 Business Developments:
Structured Data: